PROS1 Antibody

說明書

中文名稱：

PROS1兔多克隆抗體
貨號：

CSB-PA127412
規格：

￥1100
圖片：
The image on the left is immunohistochemistry of paraffin-embedded Human cervical cancer tissue using CSB-PA127412(PROS1 Antibody) at dilution 1/60, on the right is treated with fusion protein. (Original magnification: ×200)

The image on the left is immunohistochemistry of paraffin-embedded Human thyroid cancer tissue using CSB-PA127412(PROS1 Antibody) at dilution 1/60, on the right is treated with fusion protein. (Original magnification: ×200)
其他：

產品詳情
產品評價
相關產品
靶點詳情

產品詳情

Uniprot No.：

P07225
基因名：

PROS1
別名：

Preproprotein S antibody; Propiece of latent protein S antibody; PROS 1 antibody; PROS antibody; PROS_HUMAN antibody; proS1 antibody; Protein S alpha antibody; Protein Sa antibody; PS 21 antibody; PS 22 antibody; PS 23 antibody; PS 24 antibody; PS 25 antibody; PS 26 antibody; PS21 antibody; PS22 antibody; PS23 antibody; PS24 antibody; PS25 antibody; PS26 antibody; PSA antibody; THPH5 antibody; THPH6 antibody; Vitamin K dependent protein S antibody; Vitamin K-dependent plasma protein S antibody; Vitamin K-dependent protein S antibody
宿主：

Rabbit
反應種屬：

Human
免疫原：

Fusion protein of Human PROS1
免疫原種屬：

Homo sapiens (Human)
標記方式：

Non-conjugated
抗體亞型：

IgG
純化方式：

Antigen affinity purification
濃度：

It differs from different batches. Please contact us to confirm it.
保存緩沖液：

-20°C, pH7.4 PBS, 0.05% NaN3, 40% Glycerol
產品提供形式：

Liquid
應用范圍：

ELISA,IHC

推薦稀釋比：

Application	Recommended Dilution
ELISA	1:2000-1:10000
IHC	1:50-1:200

Protocols：

ELISA Protocol
Immunohistochemistry (IHC) Protocol
儲存條件：

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
貨期：

Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
用途：

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產品評價

靶點詳情

功能：

Anticoagulant plasma protein; it is a cofactor to activated protein C in the degradation of coagulation factors Va and VIIIa. It helps to prevent coagulation and stimulating fibrinolysis.
基因功能參考文獻：
1. The authors provide strong evidence that the rare Protein S Heerlen (PSH) mutation variant is associated with venous thrombosis in unselected individuals. PMID: 28374852
2. Functional PROS1 variants are more common in the general Swedish population than anticipated. PMID: 29883906
3. The present case combined with the review of the literature suggests that p.Arg451* in the PROS1 gene mainly leads to clinically evident thrombosis following trauma, surgery or serious comorbidities especially malignancy. PMID: 29321366
4. Protein S and Gas6 mediates phagocytosis of HIV-1-infected cells by bridging receptor tyrosine kinase Mer to phosphatidylserine exposed on infected cells. PMID: 29304470
5. these results suggest a novel pathogenic role of SPE B that initiates protein S degradation followed by the inhibition of apoptotic cell clearance by macrophages PMID: 27181595
6. Taken together, our gain-of-function, loss-of-function analyses suggest that PROS may facilitate cell proliferation and promote castration resistance in human castration-resistant PCa-like cells via its apoptosis-regulating property. PMID: 27342144
7. protein S has a clinical relevance and a protective role in pulmonary fibrosis PMID: 27172994
8. Due to the versatility exemplified, this probe holds great promise for exploring the role of protein S-nitrosylation in the pathophysiological process of a variety of vascular diseases PMID: 28284075
9. There was no association between PS-Tokushima and recurrent pregnancy loss and a PS deficiency or low PS activity was shown not to serve as a reliable clinical predictor of subsequent miscarriage. PMID: 28214760
10. we identify PROS1 as a driver of Oral Squamous Cell Carcinoma tumor growth and a modulator of AXL expression PMID: 28118606
11. The prevalence of PS de fi ciency in the present study was higher than in Western countries and con fi rms the high prevalence of PS de fi ciency in Asian populations PMID: 27748013
12. Patients with type 2 diabetes had significantly lower circulating free protein S than healthy control subjects PMID: 27207541
13. In the present study, gene analysis of six unrelated Japanese families diagnosed with congenital protein S deficiency identified five missense mutations in the PROS1 gene - c.757C>T (Ala139Val; A139V), c.1346 G>T (Cys449Phe; C449F), c.1352G>A (Arg451Gln; R451Q), c.1424G>T (Cys475Phe; C475F) and c.1574C>T (Ala525Val; A525V) - and one frameshift mutation, c.2135delA (Asp599ThrfsTer13; D599TfsTer13). PMID: 28088608
14. The odds ratio of developing idiopathic fatal pulmonary embolism as a variant carrier for PROS1 is 56.4 (95% CI, 5.3-351.1; P = 0.001). PMID: 28174134
15. described a novel PROS1 frameshift mutation, c.74dupA, in a hereditary protein S deficiency family. Interestingly, both of the proband and his mother carried the mutation and had a protein S deficiency, however, only the proband suffered a pulmonary embolism while his mother had no history of any thrombosis, suggesting that a triggering event might have been involved in the thrombus formation. PMID: 27846449
16. PROS1 may play an important role in the development of glioblastoma multiforme through cellular proliferation, migration and invasion as well as apoptosis. PMID: 27840905
17. Low protein S expression is associated with diabetes mellitus. PMID: 27345772
18. analysis of genotype phenotype correlation in PROS1 in a large cohort of adults with suspicion of inherited quantitative protein S deficiency PMID: 26466767
19. The immunoabsorption of PON1 from plasma significantly reduced protein S anti-coagulant activity. PMID: 26358807
20. Elevated levels of circulating microparticles can play a role in carriers of mild and severe inherited thrombophilia resulting from protein S deficiency. PMID: 26354831
21. The ELISA system using the PS K196E mutation-specific antibody is a useful tool for the rapid identification of PS K196E carriers, who are at a higher risk for venous thromboembolism. PMID: 26186226
22. A PROS1 c.1486_1490delGATTA mutation on exon 12. appeared to be the primary cause of thrombosis in the family of the present study. PMID: 25997409
23. analysis of the amino acid residues in the laminin G domains of protein S involved in tissue factor pathway inhibitor interaction PMID: 25716664
24. Women with low levels of plasma PS activity and free PS during early pregnancy might have increased risks of pregnancy-induced hypertension, or pre-eclampsia. PMID: 25879167
25. analysis of compound heterozygote protein S deficiency in two Japanese patients [case reports] PMID: 25868595
26. Protein S exacerbates acute alcoholic hepatitis by inhibiting apoptosis of activated natural killer T cells. PMID: 25399514
27. The present study highlights that the GAS6/ProS-TAM system correlates in several ways with disease activity in systemic lupus erythematosus PMID: 23497733
28. genetic polymorphism affects endogenous thrombin potential among FV Leiden carriers PMID: 24226152
29. Identical large duplication mutation of PROS1 was detected in 3 unrelated patients with thrombophilia from hereditary protein S deficiency. PMID: 24992033
30. Anti-human protein S antibody induces tissue factor expression through a direct interaction with PFKP and ERK1/2 activation in coronary artery endothelial cells. PMID: 24331211
31. Data indicate that the protein S sex hormone-binding globulin (SHBG)-like domain was important for binding and enhancement of tissue factor pathway inhibitor (TFPI). PMID: 24740810
32. study found the S K196E mutation, a genetic risk factor for venous thromboembolism, was not found in Chinese or Koreans; results suggest the protein S K196E mutation is a recent occurrence and fixed within the Japanese population PMID: 23721692
33. implicate protein S residues 37-50 as a binding site for FVa that mediates, at least in part, the direct inhibition of FVa-dependent procoagulant activity by protein S PMID: 23892573
34. miR-494 is involved in the mechanism of estrogen-mediated downregulation of PS expression PMID: 23789915
35. This is the first report of a large deletion of PROS1 from exon 1 through 12 in Polish patients with deep-vein thrombosis. PMID: 23473639
36. PS exerts anticoagulant cofactor activity with TFPIalpha from any physiological pool, likely by localizing TFPIalpha to membrane surfaces, stabilizing its interaction with membrane-bound FXa, and slowing thrombin generation. PMID: 24233490
37. Data suggest that protein S testing and PROS1 testing should not be considered in unselected patients with venous thrombosis. PMID: 24014240
38. This study is the largest investigation of ProS deficiency in China and the first investigation of the influence of Type I ProS missense mutations on the global level of coagulation function. PMID: 23813890
39. The effect of oral contraceptives on TFPI and PS is a possible explanation for the increased risk of venous thrombosis associated with oral contraceptives. PMID: 23407778
40. Data indicate that activated T cells express Pros1. PMID: 23850380
41. Platelet protein S may be an essential pool of protein S that counterbalances procoagulant activities on platelets. PMID: 23238804
42. sputum glutaredoxin-1 may have a role in asthma, while protein S may have a role in better lung function PMID: 23370801
43. The tyrosine kinase receptor MER is activated by PROS and mediates its inhibitory effect on VEGF-A-induced EC proliferation. PMID: 23065156
44. TFPI Kunitz domain 3 residue Glu226 is essential for TFPI enhancement by protein S. PMID: 23074276
45. PROS1 is elevated in high grade and castration-resistant prostate cancer and could serve as a potential biomarker of aggressive disease. PMID: 22908226
46. mutation deletions but no other types of rearrangements detected in patients with protein S deficiency PMID: 22627709
47. genetic polymorphism is associated with increased free plasma tissue factor pathway inhibitor levels PMID: 22273984
48. proteolytic cleavage is increased in patients with essential thrombocythaemia and reduced in patients with chemotherapy-induced thrombocytopenia PMID: 22318644
49. Serum of women during third trimester of pregnancy complicated by intrauterine growth restriction (IUGR) had significantly lower functional and free protein S compared with control; however, no correlation was found between total protein S and IUGR. PMID: 22104477
50. Persistently low protein S activity levels are highly indicative of a genetic alteration in PROS1. PMID: 22261441
顯示更多

收起更多
相關疾病：

Thrombophilia due to protein S deficiency, autosomal dominant (THPH5); Thrombophilia due to protein S deficiency, autosomal recessive (THPH6)
亞細胞定位：

Secreted.
組織特異性：

Plasma.
數據庫鏈接：

HGNC: 9456

OMIM: 176880

KEGG: hsa:5627

STRING: 9606.ENSP00000377783

UniGene: Hs.64016

Most popular with customers

YWHAG Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
YWHAB Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF, FC

Species Reactivity: Human, Mouse, Rat
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
XRCC5 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF

Species Reactivity: Human
XPNPEP1 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human
XDH Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WT1 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WFDC2 Recombinant Monoclonal Antibody

Applications: ELISA, WB, FC

Species Reactivity: Human